Question 1

What are the potential benefits of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma clinical trial (NCT01609036). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my safety be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma clinical trial (NCT01609036). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of information will be collected about my health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma clinical trial (NCT01609036). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks associated with rituximab that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma clinical trial (NCT01609036). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this study affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma clinical trial (NCT01609036). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma clinical trial (NCT01609036). Contact the study team or your healthcare provider for specific answers.

What this study is about